Bayer AG News Headlines

BAYRY 
$131.676
*  
3.984
2.94%
Get BAYRY Alerts
*Delayed - data as of Jul. 31, 2014  -  Find a broker to begin trading BAYRY now


Community Rating:
View:    BAYRY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog
7/31/2014 10:41:00 AM - Zacks.com

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
7/30/2014 7:00:00 PM - Zacks.com

Bayer Q2 Profit Rises 13%
7/30/2014 4:07:00 AM - RTT News

FDA Approves Bayer's Eylea for Diabetic Macular Edema Treatment
7/30/2014 3:50:00 AM - Dow Jones Business News

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog
7/29/2014 12:30:00 PM - Zacks.com

Merck Q2 Results Beat Estimates, Lifts FY14 Earnings View
7/29/2014 8:36:00 AM - RTT News

Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog
7/25/2014 2:45:00 PM - Zacks.com

Bayer and Onyx Say Phase III Trial of Nexavar Breast Cancer Treatment Failed
7/25/2014 3:21:00 AM - Dow Jones Business News

Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
7/25/2014 2:44:00 AM - RTT News

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
7/22/2014 5:20:00 PM - Zacks.com

Regeneron Shares Jump as Sanofi Increases Stake - Analyst Blog
7/2/2014 11:30:00 AM - Zacks.com

Bayer Drugs Get Positive CHMP Recommendation - Analyst Blog
6/30/2014 4:20:00 PM - Zacks.com

Bayer Inks Hemophilia Deal with Dimension Therapeutics - Analyst Blog
6/25/2014 4:45:00 PM - Zacks.com

Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog
6/25/2014 10:45:00 AM - Zacks.com

Abbott Labs to Buy Russia-Based Veropharm - Analyst Blog
6/24/2014 4:15:00 PM - Zacks.com

Bayer, Dimension Therapeutics to Develop Gene Therapy for Hemophilia
6/23/2014 6:48:00 AM - Dow Jones Business News

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
6/20/2014 3:50:00 PM - Zacks.com

Merck Begins Tender Offer To Acquire Idenix - Update
6/20/2014 9:03:00 AM - RTT News

Actelion's Selexipag Meets Primary Endpoint - Analyst Blog
6/16/2014 6:15:00 PM - Zacks.com

OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog
6/16/2014 5:22:00 PM - Zacks.com

Bayer Looking to Expand Eylea's Label - Analyst Blog
6/12/2014 5:00:00 PM - Zacks.com

German Stocks Retreat As World Bank Cuts Global Growth Forecast
6/11/2014 6:02:00 AM - RTT News

Bayer Seeks Approval Of EYLEA For Fourth Indication In EU - Quick Facts
6/11/2014 2:56:00 AM - RTT News

Merck to Buy Idenix for $3.85 Billion -- 5th Update
6/9/2014 11:09:00 AM - Dow Jones Business News

Merck to Buy Idenix for $3.85 Billion -- 3rd Update
6/9/2014 9:29:00 AM - Dow Jones Business News